Patents by Inventor Wolfgang Bender

Wolfgang Bender has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7883713
    Abstract: The invention relates to the topical application of substituted thiazolyl amides in the treatment of herpes infections in humans, to preparations suitable for the topical application and to the production thereof.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: February 8, 2011
    Assignee: AiCuris GmbH & Co. KG
    Inventors: Ulrich Betz, Tobias Laich, Wolfgang Bender, Ruediger Fischer, Martin Hendrix, Gerald Kleymann
  • Publication number: 20070004735
    Abstract: The invention relates to a method for inhibiting the replication of herpesviruses, to methods for identifying compounds which inhibit the replication of herpesviruses using this method, to compounds having activity against herpesviruses, to methods for their preparation and to their use for producing medicaments for the treatment of herpes infections.
    Type: Application
    Filed: December 24, 2003
    Publication date: January 4, 2007
    Inventors: Ulrich Betz, Guy Hewlett, Gerald Kleymann, Thomas Lampe, Tse-I Lin, Susanne Nikolic, Jurgen Reefshlager, Tobias Wunberg, Holger Zimmerman, Franz Zumpe, Wolfgang Bender, Kerstin Henninger, Axel Jensen, Jorg Keldenich, Rudolf Schohe-Loop
  • Patent number: 7115612
    Abstract: The present invention relates to novel sulphonamides of the general formula (I) in which the substituents R1, R2, R3, R4 and A and X are as defined in claim 1 and other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: October 3, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jörg Keldenich, Armin Kern, Siegfried Raddatz, Jürgen Reefschläger, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Patent number: 7115636
    Abstract: The invention relates to novel sulfonamides of general formula (I) where the substituents R1, R2, R3, R4, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: October 3, 2006
    Assignee: Bayer Healthcare AG
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jörg Keldenich, Armin Kern, Siegfried Raddatz, Jürgen Reefschläger, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Patent number: 7105553
    Abstract: The present invention relates to novel compounds, to a process for their preparation and to their use as medicaments, in particular as antiviral medicaments.
    Type: Grant
    Filed: December 12, 2000
    Date of Patent: September 12, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rüdiger Fischer, Gerald Kleymann, Ulrich Betz, Judith Baumeister, Wolfgang Bender, Peter Eckenberg, Gabriele Handke, Martin Hendrix, Kerstin Henninger, Axel Jensen, Jörg Keldenich, Udo Schneider, Olaf Weber
  • Publication number: 20050085549
    Abstract: The invention relates to novel sulfonamides of general formula (I) where the substituents R1, R2, R3, R4, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.
    Type: Application
    Filed: July 24, 2002
    Publication date: April 21, 2005
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jorg Keldenich, Armin Kern, Siegfried Raddatz, Jurgen Reefschlager, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Publication number: 20050059658
    Abstract: The invention relates to novel compounds, to a method for the production of said compounds and to the use thereof as medicaments, more particularly as antiviral agents, especially against cytomegalovirus.
    Type: Application
    Filed: June 17, 2002
    Publication date: March 17, 2005
    Inventors: Tobias Wunberg, Ulrich Betz, Sabine Hallenberger, Gerald Kleymann, Thomas Lampe, Susanne Nikolic, Jurgen Reefschlager, Franz Zumpe, Marcus Bauser, Wolfgang Bender, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Axel Jensen, Jorg Keldenich, Holger Zimmermann
  • Publication number: 20040235916
    Abstract: The invention relates to the novel compounds of formula (I), to a method for producing the same and to their use as drugs, especially as antiviral drugs.
    Type: Application
    Filed: December 19, 2003
    Publication date: November 25, 2004
    Inventors: Rudolf Schohe-Loop, Ulrich Betz, Rudiger Fischer, Martin Hendrix, Gerald Kleymann, Judith Baumeister, Wolfgang Bender, Peter Eckenberg, Gabriele Handke-Erguden, Kerstin Henninger, Axel Jensen, Jorg Keldenich, Udo Schneider, Olaf Weber
  • Publication number: 20040235917
    Abstract: The invention relates to the topical application of substituted thiazolyl amides in the treatment of herpes infections in humans, to preparations suitable for the topical application and to the production thereof.
    Type: Application
    Filed: June 30, 2004
    Publication date: November 25, 2004
    Inventors: Ulrich Betz, Tobias Laich, Wolfgang Bender, Rudiger Fischer, Martin Hendrix, Gerald Kleymann
  • Publication number: 20040176374
    Abstract: The present invention relates to novel sulphonamides of the general formula (I) 1
    Type: Application
    Filed: April 12, 2004
    Publication date: September 9, 2004
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jorg Keldenich, Armin Kern, Siegfried Raddatz, Jurgen Reefschlager, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Publication number: 20040006076
    Abstract: The present invention relates to novel compounds, to a process for their preparation and to their use as medicaments, in particular as antiviral medicaments.
    Type: Application
    Filed: November 12, 2002
    Publication date: January 8, 2004
    Inventors: Rudiger Fischer, Gerald Kleymann, Ulrich Betz, Judith Baumeister, Wolfgang Bender, Peter Eckenberg, Gabriele Handke, Martin Hendrix, Kerstin Henninger, Axel Jensen, Jorg Keldenich, Udo Schneider, Olaf Weber
  • Patent number: 6500817
    Abstract: The present invention relates to thiazolylurea derivatives, a process for their preparation, and their use as pharmaceuticals, in particular as antiviral pharmaceuticals.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: December 31, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rüdiger Fischer, Gerald Kleymann, Judith Baumeister, Wolfgang Bender, Ulrich Betz, Peter Eckenberg, Gabriele Handke, Martin Hendrix, Udo Schneider, Olaf Weber, Kerstin Henninger, Axel Jensen, Jörg Keldenich
  • Patent number: 6498183
    Abstract: The present invention relates to novel compounds which are suitable as pharmaceuticals, to processes for their preparation and to their use as pharmaceuticals, in particular as antiviral agents.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: December 24, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wolfgang Bender, Peter Eckenberg, Siegfried Goldmann, Michael Härter, Sabine Hallenberger, Jürgen Reefschläger, Jörg Trappe, Olaf Weber
  • Publication number: 20020160932
    Abstract: The present invention relates to inhibitors of the viral helicase-primase enzyme complex with anti-herpes activity, and to medicaments containing these compounds in suitable formulation. The invention further describes a method for identifying substances with antiviral activity in order to treat herpes infections in humans and animals.
    Type: Application
    Filed: August 30, 2001
    Publication date: October 31, 2002
    Inventors: Gerald Kleymann, Rudiger Fischer, Martin Hendrix, Guy Hewlett, Veniamin Pevzner, Ulrich Betz, Wolfgang Bender, Peter Eckenberg, Gabriele Handke, Udo Schneider, Olaf Weber, Kerstin Henninger, Axel Jensen, Jorg Keldenich, Judith Baumeister
  • Publication number: 20020119995
    Abstract: The present invention relates to novel compounds, i.e. inverse thiazolylamide derivatives, to processes for their preparation and to their use as medicaments, in particular as antiviral medicaments.
    Type: Application
    Filed: July 31, 2001
    Publication date: August 29, 2002
    Inventors: Martin Hendrix, Gerald Kleymann, Ulrich Betz, Judith Baumeister, Wolfgang Bender, Peter Eckenberg, Rudiger Fischer, Gabriele Handke, Kerstin Henninger, Axel Jensen, Jorg Keldenich, Udo Schneider, Olaf Weber
  • Patent number: 6417181
    Abstract: The present invention relates to new naphthyl- and anilide-substituted sulphonamides of the general formula (I) in which the substituents A, D, E, G, R1, R2, R3, R4 and X have the meanings indicated, and to processes for their preparation and their use as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: July 9, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wolfgang Bender, Jürgen Reefschläger, Peter Eckenberg, Siegfried Goldmann, Michael Härter, Sabine Hallenberger, Jörg Trappe, Olaf Weber
  • Patent number: 6250917
    Abstract: In order to create a regenerative, energy-saving fuel firing for an industrial furnace, particularly for a metal smelting furnace, that can flexibly take all possible time and space operating conditions and demands of the furnace to be heated as well as the thermic conditions of the respectively employed, heat-storing regenerators exactly into consideration, it is inventively proposed that at least two regenerator/burner modules (3) are switchable from burner mode (7) into regenerator mode (7r) (exhaust gas extraction mode) or, respectively, vice versa independently of one another proceeding from the process controller of the industrial furnace (1), namely with employment of reverse valves (11) or reversible ventilators or, respectively, two-stream ventilators.
    Type: Grant
    Filed: November 17, 1998
    Date of Patent: June 26, 2001
    Assignees: Gautschi Electro-fours S.A., Betriebsforschungsinstitut, VDEh-Institut fur angewandte Forschung GmbH
    Inventors: Ing Franz Engelberg, Martin Wicker, Gerhard Villinger, Wolfgang Bender
  • Patent number: 5876197
    Abstract: In order to create a regenerative, energy-saving fuel firing for an industrial furnace, particularly for a metal smelting furnace, that can flexibly take all possible time and space operating conditions and demands of the furnace to be heated as well as the thermic conditions of the respectively employed, heat-storing regenerators exactly into consideration, it is inventively proposed that at least two regenerator/burner modules (3) are switchable from burner mode (7) into regenerator mode (7r) (exhaust gas extraction mode) or, respectively, vice versa independently of one another proceeding from the process controller of the industrial furnace (1), namely with employment of reverse valves (11) or reversible ventilators or, respectively, two-stream ventilators.
    Type: Grant
    Filed: March 19, 1997
    Date of Patent: March 2, 1999
    Assignees: Gautschi Electro-fours S.A., BFI Betriebsforschungsinstitut, VDEh-Institut fur angewandte Forschung GmbH
    Inventors: Franz Engelberg, Martin Wicker, Gerhard Villinger, Wolfgang Bender
  • Patent number: 5571921
    Abstract: The present invention relates to substituted (2-oxo-1-benzimidazolinyl)-piperidines of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, to processes for their preparation and to their use as antiretroviral agents.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 5, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wolfgang Bender, Dieter H abich, Siegfried Raddatz, Wolfgang R oben, Hanno Wild, Jutta Hansen, Arnold Paessens
  • Patent number: 5492918
    Abstract: The present invention relates to the use of substituted chromans of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, for the production of medicaments, in particular as HIV protease-inhibiting agents, new active compounds and processes for their preparation.
    Type: Grant
    Filed: June 1, 1994
    Date of Patent: February 20, 1996
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hanno Wild, Wolfgang Bender, Dieter Habich, Hans-Georg Heine, Siegfried Raddatz, Wolfgang Roben, Jutta Hansen, Arnold Paessens